Observational Phase
PAVING THE WAY FOR DIGITAL TWINS, PATIENTS, AND DIGITAL RESEARCH SUBJECTS WITH AI-DRIVEN DATA COLLECTION
At 3S Pharma the post marketing surveillance after Phase IV of a clinical trial is a very important asset of a new drug market performance data collection. These studies are focused on the observation of patients, rather than on the drug itself.
We provide this advantage to our partners through observational studies design, using personalized methods like surveys and interviews, or medical records and other datasets. Our goal is to observe and extract relevant insights about the medication, without influencing the treatment.
At 3S Pharma, we are proficient in cohort and cross sectional studies, as part of the Observational studies.
We create for our partners the design of their Observational studies, and we also provide the specialized infrastructure to conduct both descriptive and analytical aspects of these studies.
That is why, each of our Observational studies is unique and provides accurate and personalized results, hard to be reproduced by another investigator.
Why work with 3S Pharma CRO
Having more than 25 years of experience in designing and implementing all phases of a clinical study internationally, at 3S Pharma we provide A to Z clinical trials solutions based upon the clients’ needs and our subjects’ safety, without compromising legal regulations.
All of our studies are based on an excellent quality management system, time and cost efficiency.
Relevant data about 3S Pharma
- +1500 registered clinical studies successfully managed from A to Z
- Regulatory compliance: international validation for seamless expertise in complex clinical studies – European Authorities including those from France, Germany, Austria, The Netherlands, the FDA and others.
- 50+ team members, comprising University graduated scientists such as medical doctors, pharmacists, biologists and other support certified members.
- Owned centers of clinical trials in Romania and Moldova, with 160 beds, 2 Emergency Units and a digitized bioanalytical laboratory.
- Extended international network for Phase III and Phase IV clinical studies.
In search of a CRO partener for your Observational study? We are here for you!
Find out more about our personalized approach for your success from our specialists.
More about Observational studies
Observational studies have proven their utility in gathering relevant data about the risk factors and they, often, take less time and effort to participate. They can be implemented alongside other Observational studies, as they do not imply altering the treatment plan.
The kind of studies are either descriptive (describe and record about a specific medical asset in a specific period of time), or analytical observational studies (comparative analysis of groups of patients).
Observational studies are conducted with the purpose of studying rare phenomena of a disease / medication, to gather unknown information and data less known about a specific drug / disease, to highlight potential risk factors and monitor the course of a clinical entity.
